Skip to Content

Albert David Ltd 524075

Morningstar Rating
INR 1,197.10 +0.95 (0.08%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

524075 is trading at a 35% discount.
Price
INR 1,196.60
Fair Value
INR 9,872.92
Uncertainty
Very High
1-Star Price
INR 2,774.28
5-Star Price
INR 944.96
Economic Moat
Cqw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 524075 is a good fit for your portfolio.

Trading Information

Previous Close Price
INR 1,196.15
Day Range
INR 1,189.801,210.65
52-Week Range
INR 555.001,509.70
Bid/Ask
INR 0.00 / INR 0.00
Market Cap
INR 6.83 Bil
Volume/Avg
492 / 1,341

Key Statistics

Price/Earnings (Normalized)
10.29
Price/Sales
1.93
Dividend Yield (Trailing)
0.75%
Dividend Yield (Forward)
0.75%
Total Yield
0.75%

Company Profile

Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1,271

Valuation

Metric
524075
Price/Earnings (Normalized)
10.29
Price/Book Value
1.95
Price/Sales
1.93
Price/Cash Flow
18.86
Price/Earnings
524075

Financial Strength

Metric
524075
Quick Ratio
3.14
Current Ratio
3.61
Interest Coverage
333.02
Quick Ratio
524075

Profitability

Metric
524075
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
524075
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADydctwmhsjSydz$73.0 Bil
MKKGY
Merck KGaA ADRRfghqjxfdvHgwllyc$69.8 Bil
HLN
Haleon PLC ADRRfhwxpdxKtv$37.8 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRFssvnssnxVdms$14.6 Bil
VTRS
Viatris IncVgtsgtzsGyjl$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVfbpjnrGzpll$12.6 Bil
CTLT
Catalent IncDxvybtcqwTnjxwq$10.2 Bil
PRGO
Perrigo Co PLCBprmbcwxWydp$4.4 Bil
CURLF
Curaleaf Holdings IncWvzxgxlqqLjqv$3.7 Bil
PBH
Prestige Consumer Healthcare IncGkqstdgsSlztlr$3.6 Bil

Sponsor Center